Powerful Protection Against Life-Threatening Infections
When dealing with serious and resistant infections, you need an antibiotic that acts fast and covers wide. PRIMECIN Injection contains Amikacin 500 mg, a potent aminoglycoside antibiotic designed to combat multi-drug resistant bacteria, especially in hospital and ICU settings.
With superior activity even against gentamicin-resistant strains, PRIMECIN is trusted in critical care for managing burns, abdominal infections, urinary tract infections, and nosocomial pathogens – especially in immune-compromised patients.
What’s Inside PRIMECIN?
- Amikacin 500 mg (Injection) – A broad-spectrum aminoglycoside antibiotic with enhanced activity against gram-negative and resistant strains. Administered via IM or IV route.
Key Benefits of PRIMECIN Injection
- Broadest spectrum among aminoglycosides
- Resistant to bacterial enzyme inactivation
- Effective in immune-suppressed patients
- Treats infections caused by gentamicin-resistant organisms
- Ideal for initial management of severe lower respiratory tract infections (RTIs)
Effective In:
- Burn Wound Infections
- Recurrent Urinary Tract Infections (UTIs)
- Abdominal Infections
- Nosocomial (Hospital-Acquired) Infections
Why Choose PRIMECIN Injection?
In the battle against aggressive infections, PRIMECIN is your frontline defense. With superior bacterial coverage, fast onset, and reliability in ICU and resistant cases, this Amikacin-based injection helps save lives when every hour counts.
Manufactured by Riva Kenko Pharma, PRIMECIN Injection is trusted by infectious disease specialists, surgeons, and hospital teams for safe, effective, and powerful protection against critical infections.
Reviews
There are no reviews yet.